Sino Biopharmaceutical Limited
SBMFF
$0.9891
$0.03914.12%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.03B | 2.11B | 1.81B | 1.83B | 1.99B |
| Total Receivables | 931.64M | 969.44M | 1.01B | 1.02B | 874.16M |
| Inventory | 325.13M | 338.32M | 252.83M | 254.46M | 281.13M |
| Prepaid Expenses | 95.10M | 98.96M | 391.49M | 394.01M | 82.16M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 128.72M |
| Total Current Assets | 3.38B | 3.52B | 3.47B | 3.49B | 3.36B |
|
|
|||||
| Total Current Assets | 3.38B | 3.52B | 3.47B | 3.49B | 3.36B |
| Net Property, Plant & Equipment | 1.41B | 1.47B | 1.33B | 1.34B | 1.40B |
| Long-term Investments | 125.45M | 130.54M | 96.46M | 97.08M | 95.96M |
| Goodwill | 125.45M | 130.54M | 96.46M | 97.08M | 95.96M |
| Total Other Intangibles | 37.25M | 38.76M | 333.35M | 335.49M | 35.04M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 398.74M | 414.92M | 174.89M | 176.01M | 532.68M |
| Total Assets | 8.96B | 9.32B | 9.18B | 9.24B | 8.97B |
|
|
|||||
| Total Accounts Payable | 205.16M | 213.48M | 301.53M | 303.46M | 188.23M |
| Total Accrued Expenses | 1.05B | 1.09B | -- | -- | 947.10M |
| Short-term Debt | -- | -- | -- | -- | 19.20M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.05B | 1.09B | 1.17B | 1.18B | 1.58B |
| Total Finance Division Other Current Liabilities | 380.51M | 395.95M | 1.55B | 1.56B | 453.08M |
| Total Other Current Liabilities | 380.51M | 395.95M | 1.55B | 1.56B | 453.08M |
| Total Current Liabilities | 2.68B | 2.79B | 3.02B | 3.04B | 3.19B |
|
|
|||||
| Total Current Liabilities | 2.68B | 2.79B | 3.02B | 3.04B | 3.19B |
| Long-Term Debt | 273.56M | 284.66M | 138.99M | 139.88M | 151.52M |
| Short-term Debt | -- | -- | -- | -- | 19.20M |
| Capital Leases | 11.43M | 11.89M | 21.28M | 21.42M | 42.08M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 136.64M | 142.19M | 202.04M | 203.33M | 205.23M |
| Total Liabilities | 3.10B | 3.23B | 3.38B | 3.40B | 3.59B |
|
|
|||||
| Common Stock & APIC | 1.76B | 1.83B | 1.77B | 1.78B | 1.81B |
| Retained Earnings | 3.46B | 3.60B | 4.38B | 4.41B | 3.34B |
| Treasury Stock & Other | -843.22M | -877.44M | -1.63B | -1.64B | -850.68M |
| Total Common Equity | 4.38B | 4.56B | 4.52B | 4.55B | 4.30B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.38B | 4.56B | 4.52B | 4.55B | 4.30B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 1.48B | 1.54B | 1.28B | 1.28B | 1.09B |
| Total Equity | 5.86B | 6.10B | 5.80B | 5.83B | 5.38B |
|
|
|||||